| Name | Title | Contact Details |
|---|
HR Pharmaceuticals, Inc. is a Delaware registered corporation headquartered in York, Pennsylvania. Owner of the two (2) legacy brands of surgical lubricant: Surgilube & HR Lubricating Jelly; the standard in the medical community for over 85 years. Since the inception of HR Pharma in 2008 we have developed a reputation of quality, safety and value; these same principles date back to 1931 of producing quality products that benefit mankind. With Manufacturing Integrity and 100% compliance to ISO 9001:2008, ISO 13485:2003, cGMP requirements and the Orthodox Union, HR® creates value for our customers by continuously delivering safe and effective medical devices, pharmaceuticals & other consumer products. HR is one of central PA`s fastest growing companies. We have increased our product offering by 2000% since 2011, and are continuing this growth into 2016. We take pride in offering quality, affordable, and American made products and will continue to develop new products based on this philosophy. We emphasize a vibrant and non-bureaucratic culture which we believe has formed our meaningful and productive team.
Jeen International Corp is a Fairfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Neural Analytics was created in 2013 when the company`s co-founders were introduced to leading-edge technology in the UCLA Department of Neurology. Leo, Robert and Dan, along with key UCLA faculty and administrators, all saw the potential to commercialize this new technology and build an important company with the potential to help millions of patients around the world.
Tibion Bionic Technologies is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina.